Global Graves Disease Treatment Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Graves Disease Treatment Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Graves Disease Treatment by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Graves Disease Treatment by Country/Region, 2017, 2022 & 2028

2.2 Graves Disease Treatment Segment by Type

2.2.1 Anti-Thyroid Medication

2.2.2 Radioactive Iodine Therapy

2.3 Graves Disease Treatment Sales by Type

2.3.1 Global Graves Disease Treatment Sales Market Share by Type (2017-2022)

2.3.2 Global Graves Disease Treatment Revenue and Market Share by Type (2017-2022)

2.3.3 Global Graves Disease Treatment Sale Price by Type (2017-2022)

2.4 Graves Disease Treatment Segment by Application

2.4.1 Hospitals Pharmacies

2.4.2 Retail Pharmacies

2.5 Graves Disease Treatment Sales by Application

2.5.1 Global Graves Disease Treatment Sale Market Share by Application (2017-2022)

2.5.2 Global Graves Disease Treatment Revenue and Market Share by Application (2017-2022)

2.5.3 Global Graves Disease Treatment Sale Price by Application (2017-2022)

3 Global Graves Disease Treatment by Company

3.1 Global Graves Disease Treatment Breakdown Data by Company

3.1.1 Global Graves Disease Treatment Annual Sales by Company (2020-2022)

3.1.2 Global Graves Disease Treatment Sales Market Share by Company (2020-2022)

3.2 Global Graves Disease Treatment Annual Revenue by Company (2020-2022)

3.2.1 Global Graves Disease Treatment Revenue by Company (2020-2022)

3.2.2 Global Graves Disease Treatment Revenue Market Share by Company (2020-2022)

3.3 Global Graves Disease Treatment Sale Price by Company

3.4 Key Manufacturers Graves Disease Treatment Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Graves Disease Treatment Product Location Distribution

3.4.2 Players Graves Disease Treatment Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Graves Disease Treatment by Geographic Region

4.1 World Historic Graves Disease Treatment Market Size by Geographic Region (2017-2022)

4.1.1 Global Graves Disease Treatment Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Graves Disease Treatment Annual Revenue by Geographic Region

4.2 World Historic Graves Disease Treatment Market Size by Country/Region (2017-2022)

4.2.1 Global Graves Disease Treatment Annual Sales by Country/Region (2017-2022)

4.2.2 Global Graves Disease Treatment Annual Revenue by Country/Region

4.3 Americas Graves Disease Treatment Sales Growth

4.4 APAC Graves Disease Treatment Sales Growth

4.5 Europe Graves Disease Treatment Sales Growth

4.6 Middle East & Africa Graves Disease Treatment Sales Growth

5 Americas

5.1 Americas Graves Disease Treatment Sales by Country

5.1.1 Americas Graves Disease Treatment Sales by Country (2017-2022)

5.1.2 Americas Graves Disease Treatment Revenue by Country (2017-2022)

5.2 Americas Graves Disease Treatment Sales by Type

5.3 Americas Graves Disease Treatment Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Graves Disease Treatment Sales by Region

6.1.1 APAC Graves Disease Treatment Sales by Region (2017-2022)

6.1.2 APAC Graves Disease Treatment Revenue by Region (2017-2022)

6.2 APAC Graves Disease Treatment Sales by Type

6.3 APAC Graves Disease Treatment Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Graves Disease Treatment by Country

7.1.1 Europe Graves Disease Treatment Sales by Country (2017-2022)

7.1.2 Europe Graves Disease Treatment Revenue by Country (2017-2022)

7.2 Europe Graves Disease Treatment Sales by Type

7.3 Europe Graves Disease Treatment Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Graves Disease Treatment by Country

8.1.1 Middle East & Africa Graves Disease Treatment Sales by Country (2017-2022)

8.1.2 Middle East & Africa Graves Disease Treatment Revenue by Country (2017-2022)

8.2 Middle East & Africa Graves Disease Treatment Sales by Type

8.3 Middle East & Africa Graves Disease Treatment Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Graves Disease Treatment

10.3 Manufacturing Process Analysis of Graves Disease Treatment

10.4 Industry Chain Structure of Graves Disease Treatment

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Graves Disease Treatment Distributors

11.3 Graves Disease Treatment Customer

12 World Forecast Review for Graves Disease Treatment by Geographic Region

12.1 Global Graves Disease Treatment Market Size Forecast by Region

12.1.1 Global Graves Disease Treatment Forecast by Region (2023-2028)

12.1.2 Global Graves Disease Treatment Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Graves Disease Treatment Forecast by Type

12.7 Global Graves Disease Treatment Forecast by Application

13 Key Players Analysis

13.1 Abbott

13.1.1 Abbott Company Information

13.1.2 Abbott Graves Disease Treatment Product Offered

13.1.3 Abbott Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Abbott Main Business Overview

13.1.5 Abbott Latest Developments

13.2 GlaxoSmithKline plc

13.2.1 GlaxoSmithKline plc Company Information

13.2.2 GlaxoSmithKline plc Graves Disease Treatment Product Offered

13.2.3 GlaxoSmithKline plc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GlaxoSmithKline plc Main Business Overview

13.2.5 GlaxoSmithKline plc Latest Developments

13.3 Merck & Co

13.3.1 Merck & Co Company Information

13.3.2 Merck & Co Graves Disease Treatment Product Offered

13.3.3 Merck & Co Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck & Co Main Business Overview

13.3.5 Merck & Co Latest Developments

13.4 Pfizer, Inc

13.4.1 Pfizer, Inc Company Information

13.4.2 Pfizer, Inc Graves Disease Treatment Product Offered

13.4.3 Pfizer, Inc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Pfizer, Inc Main Business Overview

13.4.5 Pfizer, Inc Latest Developments

13.5 RLC LABS

13.5.1 RLC LABS Company Information

13.5.2 RLC LABS Graves Disease Treatment Product Offered

13.5.3 RLC LABS Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 RLC LABS Main Business Overview

13.5.5 RLC LABS Latest Developments

13.6 AbbVie, Inc

13.6.1 AbbVie, Inc Company Information

13.6.2 AbbVie, Inc Graves Disease Treatment Product Offered

13.6.3 AbbVie, Inc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 AbbVie, Inc Main Business Overview

13.6.5 AbbVie, Inc Latest Developments

13.7 Mylan N.V

13.7.1 Mylan N.V Company Information

13.7.2 Mylan N.V Graves Disease Treatment Product Offered

13.7.3 Mylan N.V Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Mylan N.V Main Business Overview

13.7.5 Mylan N.V Latest Developments

13.8 Allergan, plc

13.8.1 Allergan, plc Company Information

13.8.2 Allergan, plc Graves Disease Treatment Product Offered

13.8.3 Allergan, plc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Allergan, plc Main Business Overview

13.8.5 Allergan, plc Latest Developments

13.9 Novartis AG

13.9.1 Novartis AG Company Information

13.9.2 Novartis AG Graves Disease Treatment Product Offered

13.9.3 Novartis AG Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Novartis AG Main Business Overview

13.9.5 Novartis AG Latest Developments

13.10 Apitope

13.10.1 Apitope Company Information

13.10.2 Apitope Graves Disease Treatment Product Offered

13.10.3 Apitope Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Apitope Main Business Overview

13.10.5 Apitope Latest Developments

13.11 Amgen INC.

13.11.1 Amgen INC. Company Information

13.11.2 Amgen INC. Graves Disease Treatment Product Offered

13.11.3 Amgen INC. Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Amgen INC. Main Business Overview

13.11.5 Amgen INC. Latest Developments

13.12 Sun Pharmaceuticals Industries LTD

13.12.1 Sun Pharmaceuticals Industries LTD Company Information

13.12.2 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product Offered

13.12.3 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Sun Pharmaceuticals Industries LTD Main Business Overview

13.12.5 Sun Pharmaceuticals Industries LTD Latest Developments

13.13 Immunovant Inc

13.13.1 Immunovant Inc Company Information

13.13.2 Immunovant Inc Graves Disease Treatment Product Offered

13.13.3 Immunovant Inc Graves Disease Treatment Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Immunovant Inc Main Business Overview

13.13.5 Immunovant Inc Latest Developments

14 Research Findings and Conclusion

Table 1. Graves Disease Treatment Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Graves Disease Treatment Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Anti-Thyroid Medication

Table 4. Major Players of Radioactive Iodine Therapy

Table 5. Global Graves Disease Treatment Sales by Type (2017-2022) & (K Units)

Table 6. Global Graves Disease Treatment Sales Market Share by Type (2017-2022)

Table 7. Global Graves Disease Treatment Revenue by Type (2017-2022) & ($ million)

Table 8. Global Graves Disease Treatment Revenue Market Share by Type (2017-2022)

Table 9. Global Graves Disease Treatment Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Graves Disease Treatment Sales by Application (2017-2022) & (K Units)

Table 11. Global Graves Disease Treatment Sales Market Share by Application (2017-2022)

Table 12. Global Graves Disease Treatment Revenue by Application (2017-2022)

Table 13. Global Graves Disease Treatment Revenue Market Share by Application (2017-2022)

Table 14. Global Graves Disease Treatment Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Graves Disease Treatment Sales by Company (2020-2022) & (K Units)

Table 16. Global Graves Disease Treatment Sales Market Share by Company (2020-2022)

Table 17. Global Graves Disease Treatment Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Graves Disease Treatment Revenue Market Share by Company (2020-2022)

Table 19. Global Graves Disease Treatment Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Graves Disease Treatment Producing Area Distribution and Sales Area

Table 21. Players Graves Disease Treatment Products Offered

Table 22. Graves Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Graves Disease Treatment Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Graves Disease Treatment Sales Market Share Geographic Region (2017-2022)

Table 27. Global Graves Disease Treatment Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Graves Disease Treatment Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Graves Disease Treatment Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Graves Disease Treatment Sales Market Share by Country/Region (2017-2022)

Table 31. Global Graves Disease Treatment Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Graves Disease Treatment Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Graves Disease Treatment Sales by Country (2017-2022) & (K Units)

Table 34. Americas Graves Disease Treatment Sales Market Share by Country (2017-2022)

Table 35. Americas Graves Disease Treatment Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Graves Disease Treatment Revenue Market Share by Country (2017-2022)

Table 37. Americas Graves Disease Treatment Sales by Type (2017-2022) & (K Units)

Table 38. Americas Graves Disease Treatment Sales Market Share by Type (2017-2022)

Table 39. Americas Graves Disease Treatment Sales by Application (2017-2022) & (K Units)

Table 40. Americas Graves Disease Treatment Sales Market Share by Application (2017-2022)

Table 41. APAC Graves Disease Treatment Sales by Region (2017-2022) & (K Units)

Table 42. APAC Graves Disease Treatment Sales Market Share by Region (2017-2022)

Table 43. APAC Graves Disease Treatment Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Graves Disease Treatment Revenue Market Share by Region (2017-2022)

Table 45. APAC Graves Disease Treatment Sales by Type (2017-2022) & (K Units)

Table 46. APAC Graves Disease Treatment Sales Market Share by Type (2017-2022)

Table 47. APAC Graves Disease Treatment Sales by Application (2017-2022) & (K Units)

Table 48. APAC Graves Disease Treatment Sales Market Share by Application (2017-2022)

Table 49. Europe Graves Disease Treatment Sales by Country (2017-2022) & (K Units)

Table 50. Europe Graves Disease Treatment Sales Market Share by Country (2017-2022)

Table 51. Europe Graves Disease Treatment Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Graves Disease Treatment Revenue Market Share by Country (2017-2022)

Table 53. Europe Graves Disease Treatment Sales by Type (2017-2022) & (K Units)

Table 54. Europe Graves Disease Treatment Sales Market Share by Type (2017-2022)

Table 55. Europe Graves Disease Treatment Sales by Application (2017-2022) & (K Units)

Table 56. Europe Graves Disease Treatment Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Graves Disease Treatment Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Graves Disease Treatment Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Graves Disease Treatment Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Graves Disease Treatment Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Graves Disease Treatment Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Graves Disease Treatment Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Graves Disease Treatment Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Graves Disease Treatment Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Graves Disease Treatment

Table 66. Key Market Challenges & Risks of Graves Disease Treatment

Table 67. Key Industry Trends of Graves Disease Treatment

Table 68. Graves Disease Treatment Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Graves Disease Treatment Distributors List

Table 71. Graves Disease Treatment Customer List

Table 72. Global Graves Disease Treatment Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Graves Disease Treatment Sales Market Forecast by Region

Table 74. Global Graves Disease Treatment Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Graves Disease Treatment Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Graves Disease Treatment Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Graves Disease Treatment Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Graves Disease Treatment Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Graves Disease Treatment Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Graves Disease Treatment Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Graves Disease Treatment Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Graves Disease Treatment Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Graves Disease Treatment Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Graves Disease Treatment Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Graves Disease Treatment Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Graves Disease Treatment Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Graves Disease Treatment Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Graves Disease Treatment Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Graves Disease Treatment Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Graves Disease Treatment Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Graves Disease Treatment Revenue Market Share Forecast by Application (2023-2028)

Table 92. Abbott Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors

Table 93. Abbott Graves Disease Treatment Product Offered

Table 94. Abbott Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Abbott Main Business

Table 96. Abbott Latest Developments

Table 97. GlaxoSmithKline plc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors

Table 98. GlaxoSmithKline plc Graves Disease Treatment Product Offered

Table 99. GlaxoSmithKline plc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. GlaxoSmithKline plc Main Business

Table 101. GlaxoSmithKline plc Latest Developments

Table 102. Merck & Co Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors

Table 103. Merck & Co Graves Disease Treatment Product Offered

Table 104. Merck & Co Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Merck & Co Main Business

Table 106. Merck & Co Latest Developments

Table 107. Pfizer, Inc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors

Table 108. Pfizer, Inc Graves Disease Treatment Product Offered

Table 109. Pfizer, Inc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Pfizer, Inc Main Business

Table 111. Pfizer, Inc Latest Developments

Table 112. RLC LABS Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors

Table 113. RLC LABS Graves Disease Treatment Product Offered

Table 114. RLC LABS Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. RLC LABS Main Business

Table 116. RLC LABS Latest Developments

Table 117. AbbVie, Inc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors

Table 118. AbbVie, Inc Graves Disease Treatment Product Offered

Table 119. AbbVie, Inc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. AbbVie, Inc Main Business

Table 121. AbbVie, Inc Latest Developments

Table 122. Mylan N.V Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors

Table 123. Mylan N.V Graves Disease Treatment Product Offered

Table 124. Mylan N.V Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Mylan N.V Main Business

Table 126. Mylan N.V Latest Developments

Table 127. Allergan, plc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors

Table 128. Allergan, plc Graves Disease Treatment Product Offered

Table 129. Allergan, plc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Allergan, plc Main Business

Table 131. Allergan, plc Latest Developments

Table 132. Novartis AG Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors

Table 133. Novartis AG Graves Disease Treatment Product Offered

Table 134. Novartis AG Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 135. Novartis AG Main Business

Table 136. Novartis AG Latest Developments

Table 137. Apitope Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors

Table 138. Apitope Graves Disease Treatment Product Offered

Table 139. Apitope Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 140. Apitope Main Business

Table 141. Apitope Latest Developments

Table 142. Amgen INC. Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors

Table 143. Amgen INC. Graves Disease Treatment Product Offered

Table 144. Amgen INC. Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 145. Amgen INC. Main Business

Table 146. Amgen INC. Latest Developments

Table 147. Sun Pharmaceuticals Industries LTD Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors

Table 148. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Product Offered

Table 149. Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 150. Sun Pharmaceuticals Industries LTD Main Business

Table 151. Sun Pharmaceuticals Industries LTD Latest Developments

Table 152. Immunovant Inc Basic Information, Graves Disease Treatment Manufacturing Base, Sales Area and Its Competitors

Table 153. Immunovant Inc Graves Disease Treatment Product Offered

Table 154. Immunovant Inc Graves Disease Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 155. Immunovant Inc Main Business

Table 156. Immunovant Inc Latest Developments

List of Figures

Figure 1. Picture of Graves Disease Treatment

Figure 2. Graves Disease Treatment Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Graves Disease Treatment Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Graves Disease Treatment Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Graves Disease Treatment Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Anti-Thyroid Medication

Figure 10. Product Picture of Radioactive Iodine Therapy

Figure 11. Global Graves Disease Treatment Sales Market Share by Type in 2021

Figure 12. Global Graves Disease Treatment Revenue Market Share by Type (2017-2022)

Figure 13. Graves Disease Treatment Consumed in Hospitals Pharmacies

Figure 14. Global Graves Disease Treatment Market: Hospitals Pharmacies (2017-2022) & (K Units)

Figure 15. Graves Disease Treatment Consumed in Retail Pharmacies

Figure 16. Global Graves Disease Treatment Market: Retail Pharmacies (2017-2022) & (K Units)

Figure 17. Global Graves Disease Treatment Sales Market Share by Application (2017-2022)

Figure 18. Global Graves Disease Treatment Revenue Market Share by Application in 2021

Figure 19. Graves Disease Treatment Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Graves Disease Treatment Revenue Market Share by Company in 2021

Figure 21. Global Graves Disease Treatment Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Graves Disease Treatment Revenue Market Share by Geographic Region in 2021

Figure 23. Global Graves Disease Treatment Sales Market Share by Region (2017-2022)

Figure 24. Global Graves Disease Treatment Revenue Market Share by Country/Region in 2021

Figure 25. Americas Graves Disease Treatment Sales 2017-2022 (K Units)

Figure 26. Americas Graves Disease Treatment Revenue 2017-2022 ($ Millions)

Figure 27. APAC Graves Disease Treatment Sales 2017-2022 (K Units)

Figure 28. APAC Graves Disease Treatment Revenue 2017-2022 ($ Millions)

Figure 29. Europe Graves Disease Treatment Sales 2017-2022 (K Units)

Figure 30. Europe Graves Disease Treatment Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Graves Disease Treatment Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Graves Disease Treatment Revenue 2017-2022 ($ Millions)

Figure 33. Americas Graves Disease Treatment Sales Market Share by Country in 2021

Figure 34. Americas Graves Disease Treatment Revenue Market Share by Country in 2021

Figure 35. United States Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Graves Disease Treatment Sales Market Share by Region in 2021

Figure 40. APAC Graves Disease Treatment Revenue Market Share by Regions in 2021

Figure 41. China Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Graves Disease Treatment Sales Market Share by Country in 2021

Figure 48. Europe Graves Disease Treatment Revenue Market Share by Country in 2021

Figure 49. Germany Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Graves Disease Treatment Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Graves Disease Treatment Revenue Market Share by Country in 2021

Figure 56. Egypt Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Graves Disease Treatment Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Graves Disease Treatment in 2021

Figure 62. Manufacturing Process Analysis of Graves Disease Treatment

Figure 63. Industry Chain Structure of Graves Disease Treatment

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles